New Cloud-Based PerkinElmer Signals Notebook Helps Scientists Accelerate Drug Discovery Research

ELN Leverages Cloud- and Web-based Technology to Streamline and Centralize Scientific Data

WALTHAM, Mass.--()--PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the launch of the PerkinElmer Signals™ Notebook at the American Chemical Society (ACS) Spring National Meeting and Exposition Booth #619 PerkinElmer’s new cloud-based Electronic Laboratory Notebook solution (ELN) powers smarter science through collaboration.

Researchers and lab managers can utilize the platform to quickly compile, report and share data to accelerate drug discovery by leveraging the PerkinElmer Signals™ Notebook cloud to access, manage and author notebooks or experiments in real-time. The PerkinElmer Signals™ Notebook also enables R&D to help accelerate the pace of innovation.

“Scientists and lab managers must have the most effective and modern data management tools at their fingertips to meet the evolving demands of drug discovery today,” said David Wang, Vice President and General Manager, Informatics, PerkinElmer. “The PerkinElmer Signals™ Notebook provides powerful tools to enable users to focus on achieving breakthroughs at an accelerated pace with collaborators. Further, the new cloud-based solution can be implemented immediately for a quick return on investment.”

The PerkinElmer Signals™ Notebook allows for simple navigation that helps researchers seamlessly store, organize, share and find data. The platform is fully integrated with Microsoft Office® and Microsoft Office Online applications to further streamline processes such as directly attaching documents to experiments. The PerkinElmer Signals™ Notebook also offers cloud storage that is safe, secure and convenient for recording observations and synthesis attempts.

For more information on the PerkinElmer Signals Notebook, please visit PerkinElmer at Booth #619 at ACS Spring or at www.perkinelmer.com/product/signals-notebook-signalsn.

About PerkinElmer

PerkinElmer, Inc. is a global leader committed to innovating for a healthier world. The Company reported revenue of approximately $2.1 billion in 2016, has approximately 9,000 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE or at www.perkinelmer.com.

Follow us on Twitter @PKILifeScience.

Contacts

For PerkinElmer, Inc.
Alison Cizowski, +1-617-399-4914
perkinelmerdas@apcoworldwide.com

Contacts

For PerkinElmer, Inc.
Alison Cizowski, +1-617-399-4914
perkinelmerdas@apcoworldwide.com